Gainers
- Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 during Wednesday's pre-market session. The company's market cap stands at $2.3 million.
- Instil Bio (NASDAQ:TIL) shares rose 12.58% to $24.69. The company's market cap stands at $143.8 million.
- Sunshine Biopharma (NASDAQ:SBFM) shares increased by 11.72% to $1.62. The company's market cap stands at $6.6 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 11.57% to $1.35. The market value of their outstanding shares is at $3.8 million.
- Modular Medical (NASDAQ:MODD) shares rose 11.53% to $0.79. The market value of their outstanding shares is at $38.4 million.
- NewGenIvf Group (NASDAQ:NIVF) shares rose 11.11% to $1.1. The company's market cap stands at $4.2 million.
Losers
- Centene (NYSE:CNC) shares fell 30.2% to $39.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 billion.
- Mustang Bio (NASDAQ:MBIO) shares declined by 27.32% to $1.49. The company's market cap stands at $8.9 million.
- Genenta Science (NASDAQ:GNTA) stock decreased by 12.31% to $3.35. The market value of their outstanding shares is at $69.8 million.
- Vaxart (NASDAQ:VXRT) stock declined by 10.86% to $0.41. The market value of their outstanding shares is at $104.9 million.
- Revelation Biosciences (NASDAQ:REVB) shares fell 10.71% to $0.73.
- Soligenix (NASDAQ:SNGX) shares decreased by 9.93% to $1.27. The company's market cap stands at $4.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
GNTAGenenta Science SPA
$2.91-3.32%
MBIOMustang Bio Inc
$1.42-3.40%
MODDModular Medical Inc
$0.5170-1.41%
NIVFNewGenIvf Group Ltd
$1.06-7.99%
REVBRevelation Biosciences Inc
$1.26-1.56%
SBFMSunshine Biopharma Inc
$1.73-1.70%
SCNIScinai Immunotherapeutics Ltd
$1.481.94%
SNGXSoligenix Inc
$1.55-1.27%
SONNSonnet BioTherapeutics Holdings Inc
$4.872.53%
TILInstil Bio Inc
$17.20-2.88%
VXRTVaxart Inc
$0.35189.92%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.







